Literature DB >> 12583606

Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family.

Pasquale Florio1, Filiberto M Severi, Pasquapina Ciarmela, Giovina Fiore, Giulia Calonaci, Angelica Merola, Claudio De Felice, Marco Palumbo, Felice Petraglia.   

Abstract

The placenta and its accessory membranes amnion and chorion undertake the role of intermediary barriers and active messengers in the maternal-fetal dialog. They synthesize, metabolize, and serve as target to numerous hormones that regulate maternal and fetal physiology during pregnancy. Among these factors, corticotropin-releasing factor (CRF) has been one of the more investigated in the last decade. Increasing evidence indicates that in the event of acute or chronic metabolic, physical, or infectious stress, maternal or fetal physiologic and pathologic conditions may influence placental secretion of CRF. The current opinion is that the placenta actually takes part in a stress syndrome by releasing CRF, which may help to influence uterine perfusion, maternal metabolism, fluid balance, and possibly uterine contractility, thereby protecting the fetus from a hostile environment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12583606     DOI: 10.1385/endo:19:1:91

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  136 in total

1.  Effects of betamethasone on maternal plasma corticotropin releasing factor, ACTH and cortisol during pregnancy.

Authors:  P J Tropper; R S Goland; S L Wardlaw; H E Fox; A G Frantz
Journal:  J Perinat Med       Date:  1987       Impact factor: 1.901

2.  Circulating maternal corticotropin-releasing hormone and gonadotropin-releasing hormone in normal and abnormal pregnancies.

Authors:  K A Sorem; C B Smikle; D K Spencer; B A Yoder; M A Graveson; T M Siler-Khodr
Journal:  Am J Obstet Gynecol       Date:  1996-10       Impact factor: 8.661

3.  Corticotropin-releasing factor-like activity in human placental extracts.

Authors:  T Shibasaki; E Odagiri; K Shizume; N Ling
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

4.  Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy.

Authors:  R S Goland; S L Wardlaw; M Blum; P J Tropper; R I Stark
Journal:  Am J Obstet Gynecol       Date:  1988-10       Impact factor: 8.661

5.  Lack of effect of psychosocial stress on maternal corticotropin-releasing factor and catecholamine levels at 28 weeks' gestation.

Authors:  F Petraglia; M C Hatch; R Lapinski; M Stomati; F M Reis; L Cobellis; G S Berkowitz
Journal:  J Soc Gynecol Investig       Date:  2001 Mar-Apr

6.  Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans.

Authors:  A Sasaki; O Shinkawa; K Yoshinaga
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells.

Authors:  P Florio; M Lombardo; R Gallo; C Di Carlo; S Sutton; A R Genazzani; F Petraglia
Journal:  Placenta       Date:  1996 Jul-Aug       Impact factor: 3.481

8.  Immunoreactive corticotropin-releasing hormone in amniotic fluid.

Authors:  A Sasaki; O Shinkawa; K Yoshinaga
Journal:  Am J Obstet Gynecol       Date:  1990-01       Impact factor: 8.661

9.  Corticotropin releasing hormone- and adreno-corticotropin-like immunoreactivity in human placenta, peripheral and uterine vein plasma.

Authors:  H M Schulte; D L Healy
Journal:  Horm Metab Res Suppl       Date:  1987

10.  Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy.

Authors:  E A Linton; A V Perkins; R J Woods; F Eben; C D Wolfe; D P Behan; E Potter; W W Vale; P J Lowry
Journal:  J Clin Endocrinol Metab       Date:  1993-01       Impact factor: 5.958

View more
  5 in total

1.  The placental interleukin-6 signaling controls fetal brain development and behavior.

Authors:  Wei-Li Wu; Elaine Y Hsiao; Zihao Yan; Sarkis K Mazmanian; Paul H Patterson
Journal:  Brain Behav Immun       Date:  2016-11-09       Impact factor: 7.217

2.  Levels of maternal serum corticotropin-releasing hormone (CRH) at midpregnancy in relation to maternal characteristics.

Authors:  Yumin Chen; Claudia Holzman; Hwan Chung; Patricia Senagore; Nicole M Talge; Theresa Siler-Khodr
Journal:  Psychoneuroendocrinology       Date:  2009-12-16       Impact factor: 4.905

3.  Developmental model of depression applied to prenatal depression: role of present and past life events, past emotional disorders and pregnancy stress.

Authors:  Jacques Dayan; Christian Creveuil; Michel Dreyfus; Michel Herlicoviez; Jean-Marc Baleyte; Veronica O'Keane
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

4.  Corticotropin-releasing hormone, its binding protein and receptors in human cervical tissue at preterm and term labor in comparison to non-pregnant state.

Authors:  Aurelija Klimaviciute; Jacopo Calciolari; Emma Bertucci; Susanne Abelin-Tornblöm; Ylva Stjernholm-Vladic; Birgitta Byström; Felice Petraglia; Gunvor Ekman-Ordeberg
Journal:  Reprod Biol Endocrinol       Date:  2006-05-31       Impact factor: 5.211

5.  Expression of Stress-Mediating Genes is Increased in Term Placentas of Women with Chronic Self-Perceived Anxiety and Depression.

Authors:  Cristina A Martinez; Ina Marteinsdottir; Ann Josefsson; Gunilla Sydsjö; Elvar Theodorsson; Heriberto Rodriguez-Martinez
Journal:  Genes (Basel)       Date:  2020-07-31       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.